home / stock / sght / sght news

SGHT News and Press, Sight Sciences Inc. From 03/07/24

Stock Information
Company Name: Sight Sciences Inc.
Stock Symbol: SGHT
Market: NASDAQ
Website: sightsciences.com
Menu
SGHT SGHT Quote SGHT Short SGHT News SGHT Articles SGHT Message Board
Get SGHT Alerts

News, Short Squeeze, Breakout and More Instantly...
SGHT - Sight Sciences GAAP EPS of -$0.22 beats by $0.12, revenue of $18.8M misses by $0.6M

2024-03-07 16:18:01 ET More on Sight Sciences Sight Sciences says Q4 total revenue is expected to be between $18.6M and $18.8M Sight Sciences slips despite Medicare decision on glaucoma procedure (update) Seeking Alpha’s Quant Rating on Sight Sciences ...
SGHT - Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance

MENLO PARK, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, t...

SGHT - Expected US Company Earnings on Thursday, March 7th, 2024

Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...

SGHT - Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024

MENLO PARK, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and...
SGHT - Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting

MENLO PARK, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, to...

SGHT - CRIS, PRSO and SGHT among mid-day movers

2024-01-24 12:48:28 ET More on Mid-day movers $ stocks. Peraso Inc. (PRSO) Q3 2023 Earnings Call Transcript Sight Sciences, Inc. (SGHT) Q3 2023 Earnings Call Transcript Curis, Inc. (CRIS) Q3 2023 Earnings Call Transcript Sight Sciences says Q4 total revenue i...

SGHT - Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital

MENLO PARK, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, today announced ...
SGHT - Sight Sciences says Q4 total revenue is expected to be between $18.6M and $18.8M

2024-01-08 16:41:58 ET More on Sight Sciences Sight Sciences slips despite Medicare decision on glaucoma procedure (update) Sight Sciences climbs after update on Medicare coverage for glaucoma procedure Seeking Alpha’s Quant Rating on Sight Sciences Hi...

SGHT - Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Financial Highlights

MENLO PARK, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients' lives, today reported preli...

SGHT - It's JPM time! Which medtechs are expected to issue updates this week?

2024-01-07 17:18:52 ET More on Akoya Biosciences, Exact Sciences, etc. Guardant Health: Vast Market Opportunity, Challenging Valuation Illumina: The Divestiture Of Grail Could Unlock Significant Shareholder Value Illumina: Conditions Are Met For A Rebound Nan...
Previous 10 Next 10